Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGC
Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despite this, the broader recovery trend remains intact above 23,700. Several companies like Sun Pharma, Tata Motors, and ONGC are in focus due to significant business developments, including acquisitions, order wins, and strategic repositioning.
Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore
Acquisition of the Mumbai-based pharma, nutraceutical and cosmeceutical products company is aimed at strengthening Sun Pharma’s product portfolio.
Sun Pharma To Acquire 100% Share In Invocare Lifesciences For Rs 271 Crore
Sun Pharma described the acquisition as a strategic investment to strengthen its product portfolio.
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction
India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash deal. This strategic move aims to bolster Sun Pharma's product offerings. Innovcare, which markets pharmaceutical drugs, nutraceuticals, and cosmeceuticals, reported steady revenue growth in recent fiscal years. The transaction, expected to conclude by July 2026, is a significant step for Sun Pharma's expansion.
Nifty trades above 23,950 mark; European market advance
IT, media and realty shares advanced while metal, PSU Bank and pharma shares declined.
Nifty trades above 23,950 mark; European market advanced
IT, media and realty shares advanced while metal, PSU Bank and pharma shares declined.
Small-cap pharma stock hits 52-week high after fundraising move. Details here
Sudarshan Pharma share price has gained over 21% in one month and has jumped 56% in three months. The smallcap stock has rallied 47% in six months, and has advanced 24% in one year. Sudarshan Pharma shares have delivered multibagger returns of 400%.
Sun Pharma Share Price Live Updates: Sun Pharma's stock crosses below key technical level
Nifty ends above 23,850 mark; broader mrkt outperforms
Realty, consumer durables and auto shares advanced while pharma and media shares declined.
Anupam Rasayan becomes first company to commercialise ETFA, eyes $500 million market
Anupam Rasayan said it will continue to invest in advanced process technologies, research capabilities and sustainable manufacturing practices as part of its long-term growth strategy.
Sun Pharma Share Price Live Updates: Sun Pharma's stock faces a monthly decline
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.